Veru Rg

Late‑stage biopharma Veru Inc. develops treatments for metabolic disease, oncology, and viral ARDS. Key candidates: Enobosarm for metastatic breast cancer; Sabizabulin for severe viral lung disease; plus its FC2 female condom for dual protection.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 20
HQ: Miami

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
VERU	Veru Rg Cap: 0.0B	EQUITY	NMS	USD	US92536C1036	Active	📈